A virologist’s criticism of former NIH leaders Fauci and Collins fuels renewed scrutiny on Capitol Hill over COVID-19 origins ...
Morning Overview on MSN
Nanoparticle therapy targets lung tumors and cancer-related muscle loss
A team at Oregon State University has engineered lipid nanoparticles that deliver messenger RNA to lung tumors while ...
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...
Among adolescents and young adults, cTnI levels remain within normal ranges after mRNA-1273 vaccination, with no evidence of increased myocardial injury.
Amgen's Tepezza became the first drug approved by the FDA for thyroid eye disease (TED) in 2020, and the company is now looking to extend its role with a new, more patient-friendly formulation. The ...
Morning Overview on MSN
Virus-inspired DNA needle could improve how drugs are delivered
Researchers at Aarhus University have built a DNA nanostructure shaped like a bacteriophage needle that can recognize ...
Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced the publication of foundational data in Molecular Therapy ...
Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...
In late 2024, Sydney tech entrepreneur Paul Conyngham was told his rescue dog, Rosie, had months to live. She was battling a tennis ball-sized mast cell tumor that had resisted surgery and ...
Lehi, Utah, March 31, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results